Hypercalciuria in the syndrome of inappropriate secretion of antidiuretic hormone.

PubWeight™: 0.88‹?›

🔗 View Article (PMID 7169985)

Published in Miner Electrolyte Metab on April 01, 1982

Authors

G Decaux, Y Van Laethem, M Van Kuyck, J Mockel

Articles by these authors

Pseudomonas aeruginosa: resistance and therapeutic options at the turn of the new millennium. Clin Microbiol Infect (2007) 3.49

Mild hyponatremia and risk of fracture in the ambulatory elderly. QJM (2008) 3.28

Somatic mutations in the thyrotropin receptor gene cause hyperfunctioning thyroid adenomas. Nature (1993) 3.19

Cabergoline in the treatment of hyperprolactinemia: a study in 455 patients. J Clin Endocrinol Metab (1999) 2.43

Metabolic effects of short-term elevations of plasma cortisol are more pronounced in the evening than in the morning. J Clin Endocrinol Metab (1999) 2.06

Treating the syndrome of inappropriate ADH secretion with isotonic saline. QJM (1998) 1.71

Treatment of the syndrome of inappropriate secretion of antidiuretic hormone by urea. Am J Med (1980) 1.44

Single-drug versus combination empirical therapy for gram-negative bacillary infections in febrile cancer patients with and without granulocytopenia. Antimicrob Agents Chemother (1984) 1.41

Therapeutic recommendations for management of severe hyponatremia: current concepts on pathogenesis and prevention of neurologic complications. Clin Nephrol (1996) 1.36

Treatment of the syndrome of inappropriate secretion of antidiuretic hormone with furosemide. N Engl J Med (1981) 1.33

Serum bactericidal activity of ceftazidime and cefoperazone alone or in combination with amikacin against Pseudomonas aeruginosa and Klebsiella pneumoniae. Antimicrob Agents Chemother (1983) 1.29

Urea for long-term treatment of syndrome of inappropriate secretion of antidiuretic hormone. Br Med J (Clin Res Ed) (1981) 1.26

Clinical use of the meropenem-clavulanate combination for extensively drug-resistant tuberculosis. Int J Tuberc Lung Dis (2012) 1.23

Hypouremia in the syndrome of inappropriate secretion of antidiuretic hormone. Ann Intern Med (1980) 1.23

Hyponatremia in the syndrome of inappropriate secretion of antidiuretic hormone. Rapid correction with urea, sodium chloride, and water restriction therapy. JAMA (1982) 1.18

Hyperferritinemia in adult onset Still's disease and the hemophagocytic syndrome. J Rheumatol (1992) 1.18

Effects of morning cortisol elevation on insulin secretion and glucose regulation in humans. Am J Physiol (1996) 1.17

The changing spectrum of TSH-secreting pituitary adenomas: diagnosis and management in 43 patients. Eur J Endocrinol (2003) 1.15

Inappropriate secretion of antidiuretic hormone treated with frusemide. Br Med J (Clin Res Ed) (1982) 1.11

Neuroendocrine rhythms and sleep in aging men. Am J Physiol (1991) 1.10

Use of ceftazidime in the therapy of serious infections, including those due to multiresistant organisms. Antimicrob Agents Chemother (1983) 1.04

Prevention of brain demyelination in rats after excessive correction of chronic hyponatremia by serum sodium lowering. Kidney Int (1994) 1.04

Role of vagal neuropathy in the hyponatraemia of alcoholic cirrhosis. Br Med J (Clin Res Ed) (1986) 1.01

Therapeutic relowering of the serum sodium in a patient after excessive correction of hyponatremia. Clin Nephrol (1999) 1.01

Dual activation by thyrotropin of the phospholipase C and cyclic AMP cascades in human thyroid. Mol Cell Endocrinol (1987) 1.00

Treatment of the syndrome of inappropriate secretion of antidiuretic hormone by long loop diuretics. Nephron (1983) 1.00

Reinduction of hyponatremia improves survival in rats with myelinolysis-related neurologic symptoms. J Neuropathol Exp Neurol (1996) 0.97

Utility and limitations of biochemical parameters in the evaluation of hyponatremia in the elderly. Int Urol Nephrol (2001) 0.97

Central nervous system complications of Mycoplasma pneumoniae. J Neurol Neurosurg Psychiatry (1980) 0.96

Myopericarditis revealing adult-onset Still's disease. Acta Clin Belg (2005) 0.95

Serum bactericidal activity of cefoperazone and ceftazidime at increasing dosages against Pseudomonas aeruginosa. J Antimicrob Chemother (1983) 0.94

Azotemia (48 h) decreases the risk of brain damage in rats after correction of chronic hyponatremia. Brain Res (2000) 0.94

Urea therapy for inappropriate antidiuretic hormone secretion from tuberculous meningitis. JAMA (1980) 0.93

High uric acid and urea clearance in cirrhosis secondary to increased "effective vascular volume". Am J Med (1982) 0.93

[Review on hypertrophic osteoarthropathy and digital clubbing]. Rev Med Brux (2003) 0.92

Combined fractional excretion of sodium and urea better predicts response to saline in hyponatremia than do usual clinical and biochemical parameters. Am J Med (1995) 0.92

Serum bactericidal activity of aztreonam, cefoperazone, and amikacin, alone or in combination, against Escherichia coli, Klebsiella pneumoniae, Serratia marcescens, and Pseudomonas aeruginosa. Antimicrob Agents Chemother (1984) 0.91

Ceftazidime as a single agent in the treatment of severe Pseudomonas aeruginosa infections. J Antimicrob Chemother (1983) 0.91

Brain myelinolysis following hypernatremia in rats. J Neuropathol Exp Neurol (1996) 0.90

The treatment of severe hyponatremia. Kidney Int Suppl (1998) 0.90

Decreased basal and stimulated thyrotropin secretion in healthy elderly men. J Clin Endocrinol Metab (1989) 0.90

Comparative serum bactericidal activity against test anaerobes in volunteers receiving imipenem, clindamycin, latamoxef and metronidazole. J Antimicrob Chemother (1987) 0.89

Epidemiology and outcome of invasive pneumococcal disease among adults in Belgium, 2009-2011. Euro Surveill (2014) 0.89

High pressure liquid chromatographic quantitation of teicoplanin in human serum. J Antimicrob Chemother (1987) 0.89

Sweet's syndrome in an HIV-infected patient. AIDS (1999) 0.88

Slow-release lanreotide in the treatment of acromegaly: a study in 66 patients. Eur J Endocrinol (2000) 0.87

Limits of brain tolerance to daily increments in serum sodium in chronically hyponatraemic rats treated with hypertonic saline or urea: advantages of urea. Clin Sci (Lond) (1991) 0.86

Ectopic Cushing's syndrome and pulmonary carcinoid tumour identified by [111In-DTPA-D-Phe1]octreotide. Postgrad Med J (1998) 0.86

Demeclocycline-induced phosphate diabetes in patients with inappropriate secretion of antidiuretic hormone. N Engl J Med (1985) 0.85

Solute loss plays a major role in polydipsia-related hyponatraemia of both water drinkers and beer drinkers. QJM (2003) 0.85

[Ischemic pituitary apoplexy and cerebrovascular accident]. Neurochirurgie (1983) 0.84

Two years of replacement therapy in adults with growth hormone deficiency. Clin Endocrinol (Oxf) (1997) 0.84

Use of urea for treatment of water retention in hyponatraemic cirrhosis with ascites resistant to diuretics. Br Med J (Clin Res Ed) (1985) 0.84

Predicting gentamicin resistance from annual usage in hospital. Lancet (1986) 0.83

Pathogenesis of autonomous thyroid nodules: in vitro study of iodine and adenosine 3',5'-monophosphate metabolism. J Clin Endocrinol Metab (1988) 0.83

Thyroid stimulating immunoglobulins, like thyrotropin activate both the cyclic AMP and the PIP2 cascades in CHO cells expressing the TSH receptor. Mol Cell Endocrinol (1992) 0.83

Rapid correction of hyponatraemia with urea may protect against brain damage in rats. Clin Sci (Lond) (1989) 0.83

Hypouricemia related to a hypersecretional tubulopathy. Nephron (1983) 0.83

Treatment of chronic hyponatremia in rats by intravenous saline: comparison of rate versus magnitude of correction. Kidney Int (1992) 0.83

Carbachol and sodium fluoride, but not TSH, stimulate the generation of inositol phosphates in the dog thyroid. FEBS Lett (1987) 0.82

Argyrophilic breast carcinoma, single metastasis to the pituitary gland. Bull Cancer (1990) 0.82

Long-term treatment of hyponatremic patients with nephrogenic syndrome of inappropriate antidiuresis: personal experience and review of published case reports. Nephron Clin Pract (2012) 0.82

In vitro nonbutanol-extractable iodine release in dog thyroid. Endocrinology (1979) 0.81

Hypouricemia in cirrhosis reflects hemodynamic alterations. Metabolism (1984) 0.81

Tumor promoters as probes of protein kinase C in dog thyroid cell: inhibition of the primary effects of carbamylocholine and reproduction of some distal effects. Metabolism (1987) 0.81

Kinetics of dog thyroid secretion in vitro. Endocrinology (1978) 0.81

Stimulation of generation of inositol phosphates by carbamoylcholine and its inhibition by phorbol esters and iodide in dog thyroid cells. Biochem J (1989) 0.81

Impaired counterregulation of glucose in a patient with hypothalamic sarcoidosis. N Engl J Med (1999) 0.80

Unlike thyrotropin, thyroid-stimulating antibodies do not activate phospholipase C in human thyroid slices. J Clin Invest (1991) 0.80

Serum bactericidal activity of mezlocillin, ceftazidime, mezlocillin/ceftazidime and mezlocillin/amikacin against Klebsiella pneumoniae and Pseudomonas aeruginosa. Eur J Clin Microbiol (1986) 0.80

Stimulation by forskolin of the thyroid adenylate cyclase, cyclic AMP accumulation and iodine metabolism. Mol Cell Endocrinol (1983) 0.80

Diabetes insipidus from metastatic oat cell carcinoma: recovery after brain irradiation. Am J Med Sci (1985) 0.79

Demonstration of prolactin at the ultrastructural level in a pituitary adenoma by the use of colloidal gold labelling. J Submicrosc Cytol (1984) 0.79

Effect of chronic oral testosterone undecanoate administration on the pituitary-testicular axes of hemodialyzed male patients. Clin Nephrol (1986) 0.79

Relationship between aldosterone and sodium, potassium, and uric acid clearance in cirrhosis with and without ascites. Nephron (1986) 0.79

[Still's disease in adults]. Rev Med Brux (1991) 0.79

Moxalactam therapy of serious infections. Infection (1983) 0.78

The role of calcium and guanosine 3':5'-monophosphate in the action of acetylcholine on thyroid metabolism. Eur J Biochem (1980) 0.78

Regulation of calcium fluxes in the thyroid. Mol Cell Endocrinol (1987) 0.78

Interference of serum tonicity with the measurement of red cell mean corpuscular volume. Acta Haematol (1982) 0.78

Mechanisms of hypouricemia in the syndrome of inappropriate secretion of antidiuretic hormone. Nephron (1985) 0.78

Treatment of a bowenoid papulosis of the penis with local applications of cidofovir in a patient with acquired immunodeficiency syndrome. Arch Intern Med (2001) 0.78

A pilot study for identifying at risk thyroid lesions by means of a decision tree run on clinicocytological variables. Int J Mol Med (1999) 0.78

Chronic alcoholism: a predisposing factor for hypocalcemia in acute pancreatitis. Digestion (1980) 0.78

Contaminated enteral nutrition solutions as a cause of nosocomial bloodstream infection: a study using plasmid fingerprinting. JPEN J Parenter Enteral Nutr (1989) 0.78

Bactericidal activity and killing rate of serum against gram-positive cocci in volunteers receiving imipenem, oxacillin, vancomycin or ampicillin plus gentamicin. J Antimicrob Chemother (1987) 0.78

Function, proliferation and differentiation of the dog and human thyrocyte. Horm Metab Res Suppl (1990) 0.77

111Indium-oxine-labeled leukocytes in the diagnosis of localized infection in patients with neoplastic disease. Cancer (1984) 0.77

Urea treatment for water retention in hyponatremic congestive heart failure. Int J Cardiol (1987) 0.77

Treatment of hyponatremic cirrhosis with ascites resistant to diuretics by urea. Nephron (1986) 0.77

Lack of major hypoxia and significant brain damage in rats despite dramatic hyponatremic encephalopathy. J Lab Clin Med (1997) 0.77

Very high elevation of CA19-9 level in a patient with steatosis. Acta Gastroenterol Belg (2005) 0.77

Multidrug-resistant tuberculosis: a review of the 23 cases treated by the Saint-Pierre University Hospital (Brussels). Acta Clin Belg (2009) 0.77